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Atrial Mechanoelectrical Feedback. Introduction: The purpose of this study was to evaluate
the effects of an acute increase in atrial pressure on refractoriness (mechanoelectrical feedback) and
the vulnerability to atrial  brillation (AF) and to investigate the effects of autonomic blockade and
verapamil on mechanoelectrical feedback in humans.
Methods and Results: Right atrial pressure and effective refractory period (ERP) at the right atrial
appendage (RAA) and high right atrial septum were measured during sinus rhythm, and during
atrial and simultaneous AV pacing at a cycle length of 300 msec, either in the absence (n 5 25) or
presence (n 5 22) of pharmacologic autonomic blockade. In another 15 patients, the protocol was
performed before and after infusion of verapamil 0.15 mg/kg. In the absence of autonomic blockade,
AV pacing resulted in a higher mean right atrial pressure (11.7 6 3.3 vs 4.3 6 3.0 mmHg, P < 0.001)
and a shorter atrial RAA ERP (144 6 23 msec vs 161 6 21 msec; P < 0.001) compared with atrial
pacing; AF was induced more often during AV pacing (87%) than during atrial pacing (20%) and
was related directly to the right atrial pressure (r 5 0.39, P 5 0.004) and indirectly to the RAA ERP
(r 5 2 0.42, P < 0.001). The susceptibility to sustained AF was greatly enhanced by autonomic
blockade. Verapamil markedly attenuated the shortening of ERP and the propensity for AF that
occurred during simultaneous AV pacing.
Conclusion: An acute increase in atrial pressure during tachycardia is associated with shortening
of atrial refractoriness and a propensity for AF, i.e., atrial mechanoelectrical feedback, which may
be enhanced by autonomic blockade and attenuated by calcium channel blockade. (J Cardiovasc
Electrophysiol, Vol. 12, pp. 43-50, January 2001)
atrial  brillation, atrial refractory period, mechanoelectrical feedback
Introduction
An increase in atrial pressure predisposes to the de-
velopment of atrial  brillation (AF),1 -3 and the arrhyth-
mogenic effects of an increase in pressure may be me-
diated by the phenomenon of mechanoelectrical
feedback, in which atrial refractoriness changes in re-
sponse to mechanical stretch.4 -6 Recent experimental
studies demonstrated that mechanical stretch of atrial
myocardium results in a shortening of atrial refractori-
ness and an increase in vulnerability to AF.6 ,7 However,
prior studies in humans observed inconsistent effects of
atrial stretch on atrial refractoriness,8 -12 and arrhythmo-
genic effects have not been described. The goal of the
present study was to clarify whether atrial mechanoelec-
trical feedback occurs in humans, and whether it contrib-
utes to the generation or maintenance of AF.
Methods
Patient Characteristics
The subjects of this study were 62 patients who un-
derwent radiofrequency catheter ablation of paroxysmal
supraventricular tachycardia. Exclusion criteria consisted
of a baseline rhythm of AF or atrial  utter, the presence
of structural heart disease, the inability to achieve a
stable electrode catheter position in the right atrium
throughout the study, or sustained AF during the study
protocol requiring electrical cardioversion on more than
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two occasions. One of these exclusion criteria was
present in 14 of 76 patients who were considered for
inclusion in this study. The 62 remaining subjects con-
sisted of 32 men and 30 women (mean age 6 SD: 46 6
14 years). Mean left ventricular ejection fraction was
0.60 6 0.06, and mean left atrial diameter by echocar-
diography was 3.4 6 0.4 cm.
Electrophysiologic Procedures
Electrophysiologic procedures were performed in the
fasting state after informed consent was obtained. All
antiarrhythmic drug therapy was discontinued at least
 ve half-lives before the procedure. Three quadripolar
electrode catheters were inserted into a femoral vein and
initially positioned in the high right atrium, His-bundle
position, and right ventricular apex. Midazolam was used
for conscious sedation. Leads V1, I, II, and III and the
intracardiac electrograms were recorded on paper or op-
tical disk. Pacing was performed with a programmable
stimulator (Bloom Associates, Ltd., Reading, PA, USA)
using stimuli that had a duration of 2 msec.
Study Protocol
The study protocol was approved by the Human Re-
search Committee and was performed upon completion
of the clinically indicated portion of the electrophysi-
ologic procedure. A quadripolar electrode catheter was
positioned in the right atrial appendage (RAA) or at the
high right atrial septum (AS), such that the pacing thresh-
old was , 1 mA (mean 0.9 6 0.3). Another electrode
catheter was positioned at the right ventricular apex for
ventricular pacing. Bipolar pacing was performed at a
current strength equal to three times the stimulation
threshold to ensure stable capture during rapid pacing.
The tip of an 8-French, 65-cm sheath inserted in a
femoral vein was positioned in the right atrium to mea-
sure atrial pressure. Blood pressure was measured with
an automatic brachial blood pressure cuff. Mean right
atrial pressure and mean blood pressure were recorded
during each measurement of atrial effective refractory
period (ERP).
Atrial ERP was measured during sinus rhythm by
introducing an atrial extrastimulus after every eighth
sinus beat at an initial coupling interval of 150 msec and
increasing the coupling interval in increments of 5 msec
until there was atrial capture. Atrial ERP was de ned as
the longest S1S2 coupling interval that failed to result in
atrial capture.
Atrial ERP then was measured during atrial and si-
multaneous AV pacing at a cycle length of 300 msec, in
random order. Simultaneous AV pacing at a cycle length
of 300 msec was used to evoke an acute increase in right
atrial pressure,8 -10 and right atrial pacing at the same
cycle length was used to control for the effect of an
increase in rate on atrial ERP. After 3 minutes of con-
tinuous pacing at a cycle length of 300 msec to achieve
steady-state conditions, an atrial extrastimulus was intro-
duced at a coupling interval of 100 msec. After every
eighth drive train stimulus, the coupling interval of the
extrastimulus was increased by 5 msec, with no pause in
the drive train, until the extrastimulus that resulted in
atrial capture occurred twice in succession. Atrial and
simultaneous AV pacing were performed in a random
order, as was the pacing site within the right atrium.
To determine the effects of autonomic blockade, the
pacing protocol at the RAA and AS were performed in
the initial 25 consecutive patients in the absence of
autonomic blockade and in the next 22 consecutive pa-
tients after pharmacologic autonomic blockade. Auto-
nomic blockade was achieved by the simultaneous infu-
sion of atropine 0.04 mg/kg and propranolol 0.2 mg/kg
administered over 5 minutes.1 3 Mean patient weight was
73 6 15 kg, and mean atropine and propranolol doses
were 2.5 6 0.3 mg and 13.2 6 2.2 mg, respectively.
In another 15 consecutive patients, the effects of ve-
rapamil were determined. The pacing protocol at the
RAA was performed before and after infusion of vera-
pamil 0.15 mg/kg over 3 minutes1 4 after pharmacologic
autonomic blockade. Mean verapamil dose was 11.7 6
0.2 mg.
Difference in atrial refractoriness ( D ERP) was de ned
as the difference between the ERPs at the RAA and AS.
Susceptibility to AF was assessed by noting whether AF
was induced by the extrastimulus that resulted in atrial
capture during measurement of the atrial ERP at the
RAA. Episodes of AF had to be . 3 seconds in duration
to be counted as an episode of AF. Pacing was stopped
whenever AF occurred. If the AF lasted . 10 minutes,
electrical cardioversion was performed to restore sinus
rhythm. Because short episodes of AF can affect atrial
refractoriness for several minutes,1 5 the study protocol
was suspended for 10 minutes after spontaneous or elec-
trical cardioversion. To con rm a stable catheter posi-
tion, the atrial pacing threshold was remeasured before
every measurement of atrial ERP and after each electri-
cal cardioversion.
Statistical Analysis
Continuous variables are expressed as mean 6 1 SD.
Statistical comparisons were performed with Student’ s
t-test or by Chi-square analysis, as appropriate. Analysis
of variance was used for multiple group comparisons,
followed by a Bonferroni-corrected t-test. Logistic re-
gression analysis was performed to calculate the induc-
ibility of AF by single atrial premature stimuli during
atrial pacing and during simultaneous AV pacing at
different atrial pressures and atrial ERPs. P , 0.05 was
considered statistically signi cant.
Results
Hemodynamic Changes
During sinus rhythm, mean right atrial pressures in
the absence of autonomic blockade, in the presence of
autonomic blockade, and after infusion of verapamil did
not differ signi cantly (Table 1). During atrial pacing at
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a cycle length of 300 msec, the mean AV interval in the
absence of autonomic blockade was signi cantly shorter
than those in the presence of autonomic blockade, and
after infusion of verapamil, but did not differ signi -
cantly compared to during sinus rhythm (Table 1). Ten
patients (16%) developed 2:1 AV conduction during
atrial pacing. However, mean right atrial pressures in the
absence of autonomic blockade, in the presence of auto-
nomic blockade, and after infusion of verapamil did not
differ signi cantly and remained unchanged compared to
during sinus rhythm (Table 1).
During simultaneous AV pacing at a cycle length of
300 msec, mean right atrial pressure increased signi -
cantly compared to during sinus rhythm and atrial pac-
ing, and increased to a similar degree in the absence of
autonomic blockade, in the presence of autonomic block-
ade, and after infusion of verapamil (Table 1).
During sinus rhythm, there were no signi cant differ-
ences in mean blood pressure in the absence of auto-
nomic blockade, in the presence of autonomic blockade,
or after infusion of verapamil (Table 1). In the absence of
autonomic blockade, mean blood pressure decreased dur-
ing simultaneous AV pacing, but not during atrial pacing
(Table 1). In the presence of autonomic blockade, re-
gardless of whether or not verapamil had been infused,
there were no signi cant changes in mean blood pressure
during atrial or simultaneous AV pacing as compared to
during sinus rhythm (Table 1).
Atrial Refractoriness
No autonomic blockade
Mean sinus cycle length was 851 6 151 msec, and
mean atrial ERPs at the RAA and AS were 224 6 30
msec and 239 6 24 msec, respectively. Compared to
during sinus rhythm, the mean RAA ERP shortened
signi cantly to 161 6 21 msec during atrial pacing (P ,
0.001). There was a further shortening of the ERP at the
RAA to 144 6 23 msec during simultaneous AV pacing
(P 5 0.003; Table 2). ERP at the AS decreased signi -
cantly and to the same extent as at the RAA during atrial
and simultaneous AV pacing (Table 2).
As compared with atrial ERPs at the RAA, atrial
ERPs at the AS were signi cantly longer during sinus
rhythm and during simultaneous AV pacing, but not
during atrial pacing (Fig. 1). D ERP was not signi cantly
greater during simultaneous AV pacing than during atrial
pacing or sinus rhythm (P 5 0.2; Table 2).
Autonomic blockade
Mean sinus cycle length after autonomic blockade
was 682 6 77 msec. Mean atrial ERPs at the RAA and
AS were 216 6 12 msec and 233 6 17 msec, respec-
tively. Compared to during sinus rhythm, mean RAA
ERP shortened signi cantly to 170 6 19 msec during
atrial pacing (P , 0.001), with a further shortening to
146 6 17 mmHg during simultaneous AV pacing (P 5
0.01; Table 2). ERP at the AS decreased signi cantly and
to the same extent as at the RAA during atrial and
simultaneous AV pacing (Table 2).
As compared with atrial ERPs at the RAA, atrial
ERPs at the AS were signi cantly longer during sinus
rhythm and during simultaneous AV pacing, but not
during atrial pacing (Fig. 1). D ERP was signi cantly
greater during simultaneous AV than during sinus













(n 5 15) P Value
Mean AV interval (msec)
Sinus rhythm 156 6 54 170 6 35 184 6 24 . 0.05
Atrial pacing 172 6 54 213 6 36 226 6 40 , 0.05
Mean RAP (mmHg)
Sinus rhythm 3.6 6 2.8* 2.7 6 3.5* 3.2 6 2.8* . 0.05
Atrial pacing 4.3 6 3.0* 3.9 6 1.7* 4.3 6 2.9* . 0.05
AV pacing 11.7 6 3.3 11.3 6 4.4 13 6 2.8 . 0.05
Changes in mean RAP (mmHg)†
Atrial pacing 0.7 6 2.3* 1.3 6 1.8* 1.1 6 1.3* . 0.05
AV pacing 8.1 6 2.9 7.5 6 2.8 9.8 6 3.4 . 0.05
Mean BP (mmHg)
Sinus rhythm 86 6 7* 80 6 7 85 6 11 . 0.05
Atrial pacing 84 6 9* 83 6 15 81 6 17 . 0.05
AV pacing 72 6 16 79 6 19 80 6 12 . 0.05
Changes in mean BP (mmHg)†
Atrial pacing 2 1 6 10* 2 0.5 6 20 2 4.4 6 14 . 0.05
AV pacing 2 14 6 17 2 3 6 14 2 5.5 6 14 0.02
Variables are expressed as mean 6 1 SD.
*P , 0.05 compared with AV pacing.
†Changes in pressure as compared with sinus rhythm.
BP 5 blood pressure; RAP 5 right atrial pressure.
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Absence versus presence of autonomic blockade
Autonomic blockade had no signi cant effect on ERP
at the RAA or AS during sinus rhythm (Table 2). Auto-
nomic blockade also did not affect the response of RAA
ERP to atrial or simultaneous AV pacing (Table 2).
However, there was less shortening of ERP at the AS in
the presence than in the absence of autonomic blockade
during simultaneous AV pacing (Table 2). This resulted
in a D ERP that was greater in the presence than in the
absence of autonomic blockade during simultaneous AV
pacing (Table 2).
Effect of verapamil
Atrial ERPs measured immediately before adminis-
tration of verapamil are listed in Table 3. After admin-
istration of verapamil, mean ERP at the RAA during
sinus rhythm was 231 6 24 msec. Mean RAA ERP
decreased signi cantly during atrial pacing, with no fur-
ther signi cant change during simultaneous AV pacing
(Table 3 and Fig. 2). Verapamil signi cantly attenuated
the shortening of atrial ERP that occurred in response to
atrial and simultaneous AV pacing (Fig. 2).
Atrial Vulnerability
Absence and presence of autonomic blockade
In the setting of sinus rhythm, AF never was induced
during measurement of ERPs, either in the absence or
presence of autonomic blockade. In the setting of atrial
pacing at a cycle length of 300 msec, AF occurred during
measurement of atrial ERP in the absence and presence
of autonomic blockade in 20% and 18% of patients,
respectively.
During simultaneous AV pacing at a cycle length of
300 msec, the prevalence of AF during measurement of
atrial ERP increased signi cantly to 87% and 92% of
patients, in the absence and the presence of autonomic
blockade, respectively (Table 2).
Both in the absence and the presence of autonomic
blockade, the inducibility of AF during determination of
atrial ERP correlated with mean right atrial pressure (Fig.
3) and was inversely related to atrial ERP (Fig. 4), but
not with D ERP (r 5 0.2 and 0.3, respectively; P 5 0.5).
Autonomic blockade did not in uence the overall
prevalence of induced AF during sinus rhythm, atrial
pacing, or simultaneous AV pacing (Table 2). However,
the prevalence of AF that lasted at least 10 minutes
induced during simultaneous AV pacing was signi -
TABLE 2
Atrial Refractory Periods and Prevalence of Induced Atrial Fibrillatoin in the Absence and the Presence of Autonomic Blockade
Absence of
Autonomic
Blockade (n 5 25)
Presence of
Autonomic
Blockade (n 5 22) P Value
Mean sinus cycle length (msec) 851 6 152 682 6 77 0.02
RAA ERP (msec)
Sinus rhythm 224 6 30*‡ 216 6 12*‡ 0.4
Atrial pacing 161 6 21* 170 6 19* 0.3
AV pacing 144 6 23 146 6 17 0.6
Changes in RAA ERP (msec)†
Atrial pacing 2 62 6 28* 2 46 6 16* 0.1
AV pacing 2 80 6 38 2 70 6 15 0.9
AS ERP (msec)
Sinus rhythm 239 6 20*‡ 233 6 17*‡ 0.4
Atrial pacing 171 6 13 181 6 13 0.08
AV pacing 164 6 18 182 6 16 0.03
Changes in AS ERP (msec)†
Atrial pacing 2 67 6 28 2 52 6 24 0.1
AV pacing 2 75 6 30 2 51 6 27 0.03
D ERP (msec)
Sinus rhythm 15 6 22 17 6 26* 0.8
Atrial pacing 10 6 18 11 6 25* 0.9
AV pacing 20 6 26 36 6 16 0.04
Atrial  brillation
Sinus rhythm 0 (0%)* 0 (0%)* 1.0
Atrial pacing 5/25 (20%)* 4/22 (18%)* 1.0
AV pacing 22/25 (87%) 20/22 (91%) 1.0
Atrial  brillation, duration . 10 min
Sinus rhythm 0 (0%) 0 (0%)* 1.0
Atrial pacing 0 (0%) 0 (0%)* 1.0
AV pacing 2/22 (9%) 10/20 (50%) 0.006
Variables are expressed as mean 6 1 SD.
*P , 0.05 compared with AV pacing; ‡P , 0.05 compared with atrial pacing.
†Changes in pressure as compared with sinus rhythm.
AS 5 atrial septum; ERP 5 effective refractory period; RAA 5 right atrial appendage.
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cantly higher in the presence than in the absence of
autonomic blockade (Table 2). Logistic regression anal-
ysis demonstrated that only D ERP was correlated with
the persistence of induced AF . 10 minutes (r 5 0.4, P 5
0.03), but not with atrial ERP (r 5 0.3, P 5 0.2) or mean
right atrial pressure (r 5 0.2, P 5 0.1).
Effect of verapamil
During atrial pacing at a cycle length of 300 msec, AF
occurred during determination of atrial ERP in 13% of
patients before and after verapamil infusion. In the setting
of simultaneous AV pacing, AF occurred during determi-
nation of atrial ERP in 87% and 33% of patients, before and
after verapamil infusion, respectively.Compared with sinus
rhythm and atrial pacing, the prevalence of AF was signif-
icantly higher during simultaneous AV pacing before vera-
pamil infusion, but not after verapamil infusion (Table 3).
Discussion
Main Findings
In this study, atrial pacing at a cycle length of 300
msec with and without simultaneous ventricular pacing
allowed assessment of the effects of an acute increase in
atrial pressure independentof the effects of an increase in
heart rate. An increase in atrial pressure was found to
potentiate the shortening of atrial refractoriness that oc-
curs in response to an increase in atrial rate. It also was
found to augment heterogeneity in atrial refractoriness,
as re ected by the difference in ERPs at the RAA and
AS. The occurrence of AF during rapid pacing was
greatly enhanced by the increase in atrial pressure that
accompanied simultaneous AV pacing. These  ndings
provide evidence suggesting that the phenomenon of
mechanoelectrical feedback occurs in the human atrium.
The results of this study demonstrate that the electro-
physiologic changes associated with an increase in atrial
pressure are in uenced by autonomic tone and calcium
channel blockade. Autonomic blockade facilitated the
maintenance of AF induced during simultaneous AV
pacing, probably by promoting heterogeneity in atrial
refractoriness. On the other hand, verapamil prevented
the shortening of atrial refractoriness that was attribut-
able to an elevated atrial pressure and markedly attenu-
ated the propensity for AF.
Susceptibility to Induced AF During Rapid Pacing
In this study, a strong relationship was found between
susceptibility to AF and right atrial pressure and atrial
refractoriness. The prevalence of AF increased to beyond
90% as the right atrial pressure increased to levels . 13
mmHg and as atrial ERP shortened to values , 140 msec.
These critical values of atrial pressure and atrial ERP
were attained much more often during simultaneous AV
pacing than during atrial pacing, which explains why AF
was more common during simultaneous AV pacing.
Prior experimental studies demonstrated that shorten-
ing of atrial ERP and an increase in atrial pressure
independently increase the vulnerability to AF.7 Short-
ening of atrial refractoriness results in a decrease in atrial
wavelength, which predisposes to AF.1 6 ,1 7 The increase
in atrial pressure that occurred during simultaneous AV
pacing in this study potentiated the shortening in atrial
refractoriness that occurred during atrial pacing at a
cycle length of 300 msec and may have resulted in an
increase in the surface area of the atrium, thereby in-
creasing the likelihood of a critical number of wavelets
needed for AF to occur.1 7
Heterogeneity of Atrial Refractoriness
In this study, the difference in atrial ERPs at the RAA
and AS was used as a measure of dispersion in atrial
refractoriness and was found to be related to the devel-
opment of sustained AF. This  nding is consistent with
the results of several experimental studies demonstrating
that heterogeneity of atrial refractoriness plays an impor-
tant role in maintenance of AF.18 -20
At a constant pacing cycle length of 300 msec, the
difference in atrial ERPs between the RAA and AS was
found to be two to three times greater during simulta-
neous AV pacing as during atrial pacing. Although the
Figure 1. Atrial effective refractory period (ERP) measured during
sinus rhythm, during atrial pacing at a cycle length of 300 msec, and
during AV pacing at the right atrial appendage (n) and at the right
atrial septum ( D ) in the absence (top panel) or presence (bottom panel)
of autonomic blockade. Mean values 6 1 SD are shown. *P , 0.05
compared with sinus rhythm; **P , 0.05 compared with AV pacing.
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reason for this observation is unclear, it is possible that
the increase in atrial pressure that occurred during simul-
taneous AV pacing resulted in different degrees of
stretch at the RAA and AS, or that different parts of the
atrium respond differently to a given degree of stretch.21
Autonomic Tone
In this study, autonomic blockade signi cantly increased
the prevalence of sustained AF during rapid pacing. The
increased susceptibility to sustained AF was not attributable
to a greater degree of shortening of atrial refractoriness at
the RAA, but instead to a lesser degree of shortening in
atrial refractoriness at the AS, resulting in a greater degree
of heterogeneity in atrial refractoriness. In the absence of
autonomic blockade, it is possible that the changes in vagal
and/or sympathetic tone that occur during rapid pacing
serve to attenuate changes in dispersion of atrial refractori-
ness. The differential responses of atrial refractoriness to
autonomic blockade at different sites in the right atrium
suggest that vagal or sympathetic innervation may not be
uniform throughout the right atrium.22 ,23
Effect of Verapamil
Previous experimental studies demonstrated that me-
chanical stretch results in an increase in intracellular
calcium concentration in ventricular myocardium.24 -26
An increase in intracellular calcium may shorten the
TABLE 3
Changes in Atrial Refractory Period Before and After Verapamil
Before Verapamil After Verapamil P Value
Mean sinus cycle length (msec) 638 6 72 697 6 101 0.8
RAA ERP (msec)
Sinus rhythm 228 6 21*‡ 231 6 24*‡ 0.4
Atrial pacing 175 6 12* 191 6 14 0.002
AV pacing 148 6 25 185 6 14 , 0.001
Changes in RAA ERP (msec)†
Atrial pacing 2 53 6 28* 2 40 6 16* 0.02
AV pacing 2 80 6 22 2 46 6 27 , 0.001
Atrial  brillation
Sinus rhythm 00 (0%)* 00 (0%) 1.0
Atrial pacing 2/15 (13)* 2/15 (13%) 1.0
AV pacing 13/15 (87%) 5/15 (33%) 0.02
Atrial  brillation, duration . 10 min
Sinus rhythm 0 (0%) 0 (0%)* 1.0
Atrial pacing 0 (0%) 0 (0%)* 1.0
AV pacing 5/13 (38%) 4/5 (80%) 0.051
Variables are expressed as mean 6 1 SD.
*P , 0.05 compared with AV pacing; ‡P , 0.05 compared with atrial pacing.
†Changes in pressure as compared with sinus rhythm.
ERP 5 effective refractory period; RAA 5 right atrial appendage.
Figure 2. Atrial effective refractory period (ERP) measured at the right
atrial appendage during sinus rhythm, during atrial and AV pacing at
a cycle length of 300 msec before ( h ) and after verapamil ( ). Mean
values 6 1 SD and P values are shown. *P , 0.05 compared with
before verapamil.
Figure 3. Probability of atrial  brillation (AF) induction by a single
atrial extrastimulus plotted as a function of right atrial pressure in the
absence ( ) (r 5 0.39, P 5 0.004) or presence ( h ) (r 5 0.35, P 5
0.02) of autonomic blockade during atrial and simultaneous AV pac-
ing. Datapoints represent the prevalence of AF induced in all patients
by a single atrial extrastimulus during measurement of the atrial
effective refractory period.
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action potential duration (and shorten refractoriness) by
inhibiting transmembrane calcium in ux27 and activating
outward potassium currents such as IKl2 8 and Ito2.28 -30
Recent experimental studies also demonstrated that ve-
rapamil prevents shortening of atrial ERP due to a
stretch-induced dilation in atria.31 The  ndings of the
present study suggest that a similar dependence of
mechanoelectrical feedback on calcium in ux may be
operative in the atrium.
Prior experimental and clinical studies suggested that
the effect of tachycardia on atrial refractoriness may be
mediated by tachycardia-induced intracellular calcium
overload.3 2 ,3 3 Consistent with these  ndings, verapamil
lessened the degree of shortening in atrial refractoriness
that occurred in this study as a result of rapid atrial
pacing. However, the shortening in atrial refractoriness
that occurred as a result of an increase in atrial pressure
was completely eliminated by verapamil, suggesting that
mechanoelectrical feedback may be more dependent on
intracellular calcium loading than is tachycardia-induced
shortening of atrial refractoriness. However, because ve-
rapamil also blocks potassium channels,3 4 it is possible
that some mechanism other than calcium channel block-
ade was responsible for prevention of atrial electrome-
chanical feedback.
Prior Studies
Prior experimental studies showed that shortening of
refractoriness in response to an increase in pressure oc-
curs in both the atrium5 -7 and ventricle.35 ,3 6 In concert
with these experimental studies, the results of the present
study demonstrate that an increase in atrial pressure is
accompanied by a shortening of atrial refractoriness and
an increased propensity for AF. However, prior studies
in humans reported either no change,9 a shortening,1 0 or
a prolongation8 ,1 1 ,12 in atrial refractoriness during an
increase in atrial pressure. The reason for this discrep-
ancy is unclear, but it may be related to differences in the
basic drive cycle length used to measure refractoriness37
or in the degree of elevation of right atrial pressure.9
Limitations
A limitation of this study is that pacing was performed
at only a single cycle length of 300 msec. It is possible
that the responses to pacing would have been different at
longer or shorter pacing cycle lengths. A second limita-
tion is that atrial ERP was measured at only two right
atrial sites, yielding at best only a rough estimate of
dispersion in atrial refractoriness. Finally, all of the sub-
jects in this study were free of structural heart disease,
and the  ndings in these subjects may not apply to
patients who have heart disease.
Conclusion
The results of this study demonstrate that spontaneous
AV pacing leads to shortening of atrial refractoriness and
an enhanced propensity for AF in response to an acute
increase in atrial pressure, which may be manifestations
of atrial mechanoelectrical feedback in humans. Modu-
lation of the response of atrial refractoriness to an in-
crease in atrial pressure by  uctuations in autonomic
tone may play a role in the maintenance of AF. Further-
more, verapamil markedly attenuates the electrophysi-
ologic consequences of an acute rise in atrial pressure,
suggesting that they may be mediated by intracellular
calcium loading. Although the extent to which mecha-
noelectrical feedback contributes to the development of
clinical episodes of AF is unclear, the  ndings of this
study suggest that an increase in atrial pressure in the
setting of a rapid heart rate is likely to increase the
susceptibility to tachycardia-induced AF.
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